[January 16, 2014]

Research and Markets: 4th Biosimilars Congregation - 26th & 27th February 2014, Thistle Marble Arch Hotel, London, UK

Research and Markets (http://www.researchandmarkets.com/research/nd6jgs/4th_biosimilars) has announced the addition of the "4th Biosimilars Congregation 2014" conference to their offering.

26th & 27th February 2014, Thistle Marble Arch Hotel, London, UK

According to Global Industry Analysts Inc. the global market for biosimilars is forecast to reach US$4.8 billion by the year 2015. By 2020, some $55 Billion worth of biologic patents are due to expire. Key factors driving market growth include patent expiries of key biological drugs, cost containment measures from governments, aging population, and supporting legislations.

This conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. Hence, this 4th Biosimilars Congregation 2014 will look at the multiple facets of biosimilars, ranging from the evolving regulatory landscape and challenges in clinical development, to the legal and economic aspects.

This Biosimilars conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, biosimilar products to the market place. By atending this conference you will gain a comprehensive outlook on the key issues surrounding biosimilars. This event will provide an important platform for Biosimilars stakeholders to discuss and share best practices in expediting Biosimilars development.

Who Should Attend

CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists from the following roles:

- Biopharmaceuticals/ Biotherapeutics

- Follow on Biologics/Follow on Proteins/Biosimilars

- Biologics/Biotechnology/ Biogenerics

- Legal Affairs

- Intellectual Property

- Health Economics

- Pricing and Reimbursement

- Clinical Immunology

- Principal Scientist

- Chief Scientific Officer

- Process Control and Analytical Technologies

- Analytical Characterisation

- Regulatory Compliance

- Pharmacovigilance

- Drug Safety & Risk Management

- Quality Affairs/ Quality Control

- New Product Development

- Process Science

- Portfolio Management

- Research & Development

- Business Development

- Business Operations

- Scientific Affairs

- Commercial Affairs

- Marketing

WHY SHOULD YOU ATTEND?

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference. Whether you are on the branded or generic side, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway. Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry, research and development costs, and regulatory hurdles, which are balanced against an enormous potential for increased profit margins.

For more information visit http://www.researchandmarkets.com/research/nd6jgs/4th_biosimilars

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

[ Back To TMCnet.com's Homepage ]